stars 1 stars 2 stars 3

LexaGene Life Sciences is an early-stage company developing a novel automated PCR-based bioburden testing system. The technology will be a significant improvement in the key needs of speed, ease-of-use, and sensitivity for >95% of microbial contaminants. Our initial target market is the biopharmaceutical manufacturing industry.

LexaGene Life Sciences Questions

LexaGene Life Sciences is based in Beverly, Massachusetts.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users